Motus gi to present data at digestive disease week® 2018 showing
pure-vu® system may reduce costs and incidence of colorectal cancer
Fort lauderdale, fla.--(business wire)--motus gi holdings, inc., (nasdaq:mots) ("motus gi" or the "company"), a medical technology company dedicated to improving endoscopy outcomes and experiences, announced today that data related to the company’s pure-vu® system will be presented at digestive disease week® 2018 (“ddw”), being held june 2-5, 2018 in washington, dc. the pure-vu® system is a medical device that cleans the colon intra-procedurally to facilitate improved visualization during a colonoscopy procedure to enable a quality exam and has demonstrated effective cleaning in hundreds of procedures. the device integrates with existing colonoscopes and is activated by a convenient foot pedal to put control of cleansing the colon in physicians’ hands so they can gain clear visualization of the wall of the colon. details of the poster presentation are as follows: title: the pure-vu colon cleansing system reduces lifetime costs and incidence of colorectal cancer (crc) – a cost minimization analysispresenting author: professor ian m. gralnek md, mshs, fasgepresentation number: sa2000date and time: june 2, 2018 at 12:00 p.m. edtsession number: 5245track: technologies and procedural innovation the abstract is available on the ddw website in the online planner. following the presentation, the poster will be available on motus gi’s website in the pure-vu® publications section. motus gi will also have a booth at ddw located in the exhibit hall at booth #720. about digestive disease week® digestive disease week® (“ddw”) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery. jointly sponsored by the american association for the study of liver diseases (aasld), the american gastroenterological association (aga) institute, the american society for gastrointestinal endoscopy (asge) and the society for surgery of the alimentary tract (ssat), ddw takes place june 2- 5, 2018 at the walter e. washington convention center. the meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in gi research, medicine and technology. more information can be found at www.ddw.org. about the pure-vu® system the pure-vu® system is a 510(k) u.s. food and drug administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. the device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. the pure-vu® system has received ce mark approval in europe. about motus gi motus gi holdings, inc. is a medical technology company, with subsidiaries in the u.s. and israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. the company is focused on the development and commercialization of the pure-vu® system to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. in clinical studies to date, the pure-vu® system significantly increased the number of patients with an adequate cleansing level, according to the boston bowel preparation scale score, a validated assessment instrument. for more information, visit www.motusgi.com and connect with the company on twitter, linkedin, facebook and google+. forward-looking statements this press release contains certain forward-looking statements. forward-looking statements are based on the company's current expectations and assumptions. the private securities litigation reform act of 1995 provides a safe-harbor for forward-looking statements. these statements may be identified by the use of forward-looking expressions, including, but not limited to, "expect," "anticipate," "intend," "plan," "believe," "estimate," "potential," "predict," "project," "should," "would" and similar expressions and the negatives of those terms. prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this presentation. the company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in the company's filings with the securities and exchange commission.
